Mark Cuban launched a new online pharmacy offering significant discounts on 100 generic medications, in today's bite-sized hospital and health industry news from New York, Tennessee, and Texas.

• New York: New York appellate judge Robert Miller on Tuesday temporarily restored Gov. Kathy Hochul's (D) indoor mask mandate after a state Supreme Court judge on Monday ruled that Hochul's administration did not have the constitutional authority to implement such a mandate. Miller granted the state's request for a stay until an appellate court can hear the appeal on Friday. According to Modern Healthcare, Hochul is confident the mandate will be upheld. "As Governor, my top priority is protecting the people of this state. These measures are critical tools to prevent the spread of Covid-19, make schools and businesses safe, and save lives," she said after Miller's ruling. (Saric, Axios, 1/25; AP/Modern Healthcare, 1/25)

• Tennessee: Ardent Health Services on Jan. 12 announced that Lisa Dolan was promoted to the role of CNO. Dolan, who previously served as Ardent's VP of clinical outcomes, succeeds Laurie Bigham, who retired at the end of 2021. Before she joined Ardent, Dolan served in multiple leadership positions with Community Health Systems. Notably, Dolan has received several leadership awards, including the Shelton R. Weber Award of Leadership Excellence. (Jensik, Becker's Hospital Review, 1/24)

• Texas: The Mark Cuban Cost Plus Drug Company (MCCPDC) recently debuted an online pharmacy that will sell medications for cancer, diabetes, gastrointestinal and heart conditions, and more—with significant discounts on 100 generic medications. The price of medications will include a flat 15% fee and a $3 fee for labor. MCCPDC is attempting to cut drug costs by working both as a retailer and its own pharmacy benefits manager. "Not everyone sets the goal of being the lowest cost producer and provider," Mark Cuban said. "My goal is to make a profit while maximizing impact." According to Forbes, the company hopes to complete construction on it $11 million, 22,000 square-foot factory in Dallas by April. (Brodwin, Axios, 1/24)